Alzheimer’s is a devastating disease that affects millions of people in the US alone, so there was a lot of excitement about recent news headlines of a drug approved to treat the disease. However, the approval was met with an outcry from several medical experts. In today’s episode, we talk about the data behind the drug and the why behind the controversy.